# Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

> **NCT01356420** · NA · TERMINATED · sponsor: **Oregon Health and Science University** · enrollment: 21 (actual)

## Conditions studied

- Smith-Lemli-Opitz Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Cholesterol supplementation

## Key facts

- **NCT ID:** NCT01356420
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** NICHD cut funding
- **Last updated:** 2019-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356420, "Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01356420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*